Avalo Therapeutics, Inc. (AVTX) total debt

Total debt · fiscal 2025
$392.00K

Avalo Therapeutics, Inc. (AVTX) carried total debt of $392.00K at the end of fiscal 2025 (December 31, 2025). That is 31.0% lower than the $568.00K of fiscal 2024. Figures as of 18 Nov 2026, 04:25 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$392.00K
Change on fiscal 2024
−31.0%
Growth, 10 years
−23.3% a year
Highest on record
$19.95Mfiscal 2022
Lowest on record
$0.00fiscal 2017
Fiscal years on record
92014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Avalo Therapeutics, Inc. total debt, in more detail

Over the ten fiscal years to 2025 total debt shrank at a compound 23.3% a year. Across the 9 fiscal years on record (2014–2025), the highest was $19.95M in fiscal 2022 and the lowest $0.00 in fiscal 2017.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 9 fiscal years

Total debt by fiscal year

Avalo Therapeutics, Inc. total debt, year by year

Avalo Therapeutics, Inc. (AVTX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$392.00K 31.0% down0.0×
2024$568.00K 5.8% up0.0×
2023$537.00K 97.3% down0.1×
2022$19.95M——
2018$15.38M—0.7×
2017$0.00 100.0% down0.0×
2016$2.35M 57.7% down11.4×
2015$5.56M 22.9% down0.4×
2014$7.21M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on AVTX

Avalo Therapeutics, Inc., figure by figure

Avalo Therapeutics, Inc. (AVTX) overview: price, valuation and scorecard

Avalo Therapeutics, Inc. total debt: questions and answers

How much debt does Avalo Therapeutics, Inc. have?

Avalo Therapeutics, Inc. (AVTX) carried total debt of $392.00K at the end of fiscal 2025 (December 31, 2025). That is 31.0% lower than the $568.00K of fiscal 2024.

What is the growth rate of Avalo Therapeutics, Inc.'s total debt?

Over the ten fiscal years to 2025 total debt shrank at a compound 23.3% a year.

What are the highest and lowest total debt figures on record for Avalo Therapeutics, Inc.?

Across the 9 fiscal years on record (2014–2025), the highest was $19.95M in fiscal 2022 and the lowest $0.00 in fiscal 2017.

How does Avalo Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Avalo Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Avalo Therapeutics, Inc. (AVTX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/AVTX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.